Australasian Virology Society
banner
ausvirologysoc.bsky.social
Australasian Virology Society
@ausvirologysoc.bsky.social
The Australasian Virology Society was incorporated in 2011 following 10 years as a group. We serve the Australasian virology community and hold biennial meetings.
Attention virologists - Upcoming Keystone Virology meeting #KSEmergingVirus26
February 16, 2025 at 12:14 AM
Excellent Flaviviridae meeting (Flaviviruses and hepatitis C virus) October 13th-16th, 2025 Singapore - don't miss out on hearing our Keynote Dan Barouche speak so close to home! Details to follow!
January 29, 2025 at 10:48 PM
Some reflections on Paul’s journey.
Finally also “follow the data, not the hypothesis”
December 5, 2024 at 5:39 AM
Adventures in Science, the journey from virology as a second choice honours project at QIMR to three mature first generation Young labs (the Watterson, Chappell and Muller groups).
December 5, 2024 at 5:34 AM
Now we are honoured to hear from the first Paul Young’s Oration at #AVS12, delivered by our very own Prof Paul Young - A Virologist’s Adventures in Wonderland. @profpaulyoung.bsky.social was the first president and vision behind the Australasian Society for Virology. Take it away Paul.
December 5, 2024 at 5:20 AM
Last data talk of the conference is
The @amersocvirology.bsky.social
Ann Palmenberg Junior Investigator Award winner Jenna Guthmiller who is going to talk about Antigenic drift within the receptor binding site differentially modulates sialic acid binding by H1N1 viruses #AVS12
December 5, 2024 at 4:57 AM
Pivoting to HCV is Arunasingam Abayasingam (UNSW) who is taking us through the Affinity of Transmitted/Founder virus associates with early emergence of Hepatitis C Virus specific neutralising antibodies #AVS12
December 5, 2024 at 4:37 AM
Ariel Isaacs (SCMB, UQ), is next up presenting a protective bispecific antibody that targets both Nipah virus surface glycoproteins and limits viral escape. #Nipah is highly pathogenic (50-100% mortality) with no approved treatments/vaccines. Check him out next week at #Hendra30 #AVS12
December 5, 2024 at 4:20 AM
Next up is Samantha Davis @iamdrsam.bsky.social (ACDP, CSIRO) who is discussing New Insights Into Immune Dysregulation at the cellular and transcriptional level Following Infection of Domestic Pigs With Virulent African Swine Fever Virus. ASFV is fatal in pigs in almost 100% of cases #AVS12
December 5, 2024 at 4:06 AM
Kicking off our final data session on Adaptive immunity chaired by Lara Herrero & Naphak Modhiran is our plenary speaker Stephanie Gras (La Trobe University) @graslab.bsky.social on COVID: what else is to be discovered? #AVS12
December 5, 2024 at 3:38 AM
“Pivoting back to sex and drugs” is Bethany Horsburgh (Kirby institute) presenting a novel long-range sequencing assay and verification for #HIV and #HCV for use in a diagnostic/clinical setting #AVS12 This tiling PCR method is sensitive and robust (131/134 sequenced!), best chance at adoption?
December 5, 2024 at 2:32 AM
If you’re eligible for the clinical trial or know someone that is please consider enrolling: www.usc.edu.au/community/un...
December 5, 2024 at 2:20 AM
Now we are hearing from Andrew Young (ViceBio/UQ) who is sharing work on a uniquely Australian virology invention in the vaccine space: The Molecular Clamp Platform: A broadly applicable solution to the manufacture of multivalent subunit vaccines for respiratory viruses. #AVS12
December 5, 2024 at 2:12 AM
The Australasian Virology Society now offers Fellowship of AVS (FASV) for those who have demonstrated exceptional professional achievement and distinction in virology, and have shown commitment to A S. www.avs.org.au/fellowship-o... Our first FASV fellow is Paul Young @profpaulyoung.bsky.social
December 5, 2024 at 1:27 AM
Finishing up our Indigenous Oral presentations session today is Natasha Jansz (Doherty Institute) who is talking about the #HTLV-1C genomic landscape reveals host-virus interactions in a humanised mouse model of infection. #AVS12
December 5, 2024 at 12:31 AM
Rounding out the virus evolution session is Nayomi Danthanarayana (CSIRO) who is discussing the Diversity of insect-specific viruses in Culex mosquitoes collected in Papua New Guinea. What viruses are lurking in PNG!? #AVS12
December 4, 2024 at 10:27 PM
Next up is Marios Koutsakos @marioskoutsakos.bsky.social who is presenting Antigenic evolution of the influenza B virus HA over 80 years of circulation in humans. Marios has apologised for only including one phylogenetic tree in his talk in this evolutionary virology session. #AVS12
December 4, 2024 at 10:11 PM
It wouldn’t be a virus evolution session without a SARS2 talk and we hand it over to Ahmed Abdul Quadeer (University of Melbourne) who is presenting on Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals #AVS12
December 4, 2024 at 9:55 PM
Take home messages: Life began in the ocean; many viral lineages likely first emerged there as well.
December 4, 2024 at 9:48 PM
Next up is Mary Petrone @marypetrone.bsky.social who is Extending the evolutionary history of disease-causing RNA viruses. Mary has been sampling marine invertebrates and makes a compelling case that sponges and tunicates are exciting hot beds of virus evolution. #AVS12
December 4, 2024 at 9:46 PM
Welcome to the last day of #AVS12 Kicking off our Virus evolution session is our invited speaker Erin Harvey @erinharvey.bsky.social discussing the Macro-scale evolution of mammalian viruses. Aussie Marsupials are one of the basal lineages within mammals and are an interesting group for discovery.
December 4, 2024 at 9:23 PM
Last up is a prerecorded presentation from Dong Li (Westmead) with @thatliverguy.bsky.social who is Investigating HBV DNA integration and its role in genomic instability through HBx expression (Poster #116)
And that finishes up the second Science Bites session, let’s go for tea! #AVS12
December 4, 2024 at 4:05 AM
Second last is PhD student Ellesandra C Noye (Short Lab/UQ) showing that Natural killer cells in children with obesity have a ‘trained’ immune phenotype and heightened pro-inflammatory responses to ex vivo influenza A virus stimulation (Poster #114) #AVS12 Maybe an epigenetic effect!?
December 4, 2024 at 4:01 AM
Next up, the man the myth the legend Danushka Wijesundara (Vaxxas/UQ) talking about the Superior Efficacy of the High Density Microarray Patch for Delivering a Novel Zika DNA Vaccine Targeting Non-structural Protein 1 (Poster #112). The HD-MAP platform is a game changer for vaccination #AVS12
December 4, 2024 at 3:58 AM
Up next is the Development of an mRNA-LNP vaccine to prevent against the awful and neglected #HTLV-1 subtype C infection. From Samantha L Grimley (Doherty Institute) (Poster #110) In remote First Nations communities in Australia, rates of infection can be as high as 40%! #AVS12
December 4, 2024 at 3:55 AM